-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Yakkang Biotech, on July 21, Yakkang Biotech and GCCL, a Korean clinical trial sample analysis company, officially signed a memorandum of strategic cooperation. The two sides will jointly provide integrated drug discovery and development services for global pharmaceutical and biotechnology companies. The cooperation between the two sides will take the lead in covering diseases such as oncology and immunity, and will focus on internal CAR-T therapy, etc.

Zhitongcaijing·07/22/2026 01:49:02
Listen to the news
According to Yakkang Biotech, on July 21, Yakkang Biotech and GCCL, a Korean clinical trial sample analysis company, officially signed a memorandum of strategic cooperation. The two sides will jointly provide integrated drug discovery and development services for global pharmaceutical and biotechnology companies. The cooperation between the two sides will take the lead in covering diseases such as oncology and immunity, and will focus on internal CAR-T therapy, etc.